Seeking Alpha

Horizon, Pozen jump after Vimovo deal

  • Moving sharply higher in early trading are shares of Horizon Pharma (HZNP +28.6%) and Pozen (POZN +13.6%) .
  • Investors are clearly upbeat on HZNP's move to acquire the U.S. rights to Vimovo.
  • For more on the deal see here.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: